San Francisco, CA, United States of America

Miranda Broz

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: University of California. Active years: 2019-2022.

USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Miranda Broz

Introduction

Miranda Broz is a prominent inventor based in San Francisco, CA. She has made significant strides in the field of immunology, particularly in enhancing immune responses and treating immune-related conditions. With a total of 2 patents, her work is paving the way for advancements in cancer treatment.

Latest Patents

Miranda's latest patents focus on the modulation of stimulatory and non-stimulatory myeloid cells. These patents provide methods and compositions for enhancing an immune response and treating immune-related conditions in individuals, such as cancer. The innovative approach involves killing, disabling, or depleting non-stimulatory myeloid cells using an antigen binding protein, such as an antibody or an antigen binding fragment thereof.

Career Highlights

Miranda is affiliated with the University of California, where she conducts her research and develops her inventions. Her work is characterized by a commitment to improving health outcomes through scientific innovation.

Collaborations

Some of her notable coworkers include Matthew F Krummel and Denise Wolf, who contribute to her research endeavors and collaborative projects.

Conclusion

Miranda Broz's contributions to immunology and cancer treatment through her patents highlight her role as an influential inventor. Her innovative methods are set to make a lasting impact in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…